Home Cart Sign in  
Chemical Structure| 98079-52-8 Chemical Structure| 98079-52-8

Structure of Lomefloxacin HCl
CAS No.: 98079-52-8

Chemical Structure| 98079-52-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Lomefloxacin HCl is a fluoroquinolone antibiotic used to treat bacterial infections including bronchitis and urinary tract infections, and prevent urinary tract infections prior to surgery.

Synonyms: SC47111A hydrochloride; Lomefloxacin (hydrochloride); SC-47111

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Lomefloxacin HCl

CAS No. :98079-52-8
Formula : C17H20ClF2N3O3
M.W : 387.81
SMILES Code : [H+].C1=C3C(=C(F)C(=C1F)N2CC(NCC2)C)N(CC)C=C(C3=O)C(O)=O.[Cl-]
Synonyms :
SC47111A hydrochloride; Lomefloxacin (hydrochloride); SC-47111
MDL No. :MFCD00214312
InChI Key :KXEBLAPZMOQCKO-UHFFFAOYSA-N
Pubchem ID :68624

Safety of Lomefloxacin HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02099240 Osteomyelitis Early Phase 1 Recruiting September 2019 United States, Kentucky ... More >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Julio A Ramirez, MD    502-852-1148    jarami01@louisville.edu    Contact: David Seligson, MD    502-852-0923    d0seli01@louisville.edu    Sub-Investigator: Forest Arnold, DO          Sub-Investigator: Timothy Wiemkwn, PhD          Sub-Investigator: Robert Kelley, PhD          Sub-Investigator: James Summersgill, PhD          Sub-Investigator: Ruth Carrico, PhD          Sub-Investigator: Julie Harting, PharmD          Sub-Investigator: Paula Peyrani, MD          Principal Investigator: David Seligson, MD          Sub-Investigator: Craig Roberts, MD          Principal Investigator: Julio Ramirez, MD Less <<
NCT00258102 Urinary Tract Infections ... More >> Bacterial Infections Bacteriuria Urologic Diseases Less << Phase 3 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.58mL

0.52mL

0.26mL

12.89mL

2.58mL

1.29mL

25.79mL

5.16mL

2.58mL

References

 

Historical Records

Categories